GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sysmex Corp (OTCPK:SSMXY) » Definitions » Cyclically Adjusted Price-to-FCF

Sysmex (Sysmex) Cyclically Adjusted Price-to-FCF : 66.12 (As of Jun. 10, 2024)


View and export this data going back to 2011. Start your Free Trial

What is Sysmex Cyclically Adjusted Price-to-FCF?

As of today (2024-06-10), Sysmex's current share price is $16.53. Sysmex's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 was $0.25. Sysmex's Cyclically Adjusted Price-to-FCF for today is 66.12.

The historical rank and industry rank for Sysmex's Cyclically Adjusted Price-to-FCF or its related term are showing as below:

SSMXY' s Cyclically Adjusted Price-to-FCF Range Over the Past 10 Years
Min: 59.05   Med: 88.53   Max: 149.58
Current: 69.04

During the past years, Sysmex's highest Cyclically Adjusted Price-to-FCF was 149.58. The lowest was 59.05. And the median was 88.53.

SSMXY's Cyclically Adjusted Price-to-FCF is ranked worse than
75% of 236 companies
in the Medical Devices & Instruments industry
Industry Median: 42.675 vs SSMXY: 69.04

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Sysmex's adjusted free cash flow per share data for the three months ended in Mar. 2024 was $0.124. Add all the adjusted free cash flow per share for the past 10 years together and divide 10 will get our Cyclically Adjusted FCF per Share, which is $0.25 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Sysmex Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Sysmex's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sysmex Cyclically Adjusted Price-to-FCF Chart

Sysmex Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 89.86 123.54 84.08 75.36 70.13

Sysmex Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 75.36 83.84 61.08 69.74 70.13

Competitive Comparison of Sysmex's Cyclically Adjusted Price-to-FCF

For the Medical Instruments & Supplies subindustry, Sysmex's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sysmex's Cyclically Adjusted Price-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Sysmex's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Sysmex's Cyclically Adjusted Price-to-FCF falls into.



Sysmex Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Sysmex's Cyclically Adjusted Price-to-FCF for today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/ Cyclically Adjusted FCF per Share
=16.53/0.25
=66.12

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sysmex's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Sysmex's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.124/107.2000*107.2000
=0.124

Current CPI (Mar. 2024) = 107.2000.

Sysmex Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 0.011 98.000 0.012
201409 0.127 98.500 0.138
201412 0.036 97.900 0.039
201503 0.136 97.900 0.149
201506 -0.030 98.400 -0.033
201509 0.136 98.500 0.148
201512 0.021 98.100 0.023
201603 0.144 97.900 0.158
201606 -0.057 98.100 -0.062
201609 0.149 98.000 0.163
201612 -0.020 98.400 -0.022
201703 0.134 98.100 0.146
201706 0.073 98.500 0.079
201709 0.118 98.800 0.128
201712 0.077 99.400 0.083
201803 0.117 99.200 0.126
201806 -0.019 99.200 -0.021
201809 0.103 99.900 0.111
201812 0.060 99.700 0.065
201903 0.081 99.700 0.087
201906 0.031 99.800 0.033
201909 0.167 100.100 0.179
201912 0.030 100.500 0.032
202003 0.168 100.300 0.180
202006 0.050 99.900 0.054
202009 0.121 99.900 0.130
202012 0.151 99.300 0.163
202103 0.144 99.900 0.155
202106 0.102 99.500 0.110
202109 0.242 100.100 0.259
202112 0.035 100.100 0.037
202203 0.005 101.100 0.005
202206 -0.060 101.800 -0.063
202209 0.171 103.100 0.178
202212 0.002 104.100 0.002
202303 0.188 104.400 0.193
202306 0.014 105.200 0.014
202309 0.077 106.200 0.078
202312 -0.071 106.800 -0.071
202403 0.124 107.200 0.124

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Sysmex  (OTCPK:SSMXY) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Sysmex Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Sysmex's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Sysmex (Sysmex) Business Description

Traded in Other Exchanges
Address
1-5-1 Wakinohara-Kaigandori, Chuo-ku, Hyogo Prefecture, Kobe, JPN, 6510073
Sysmex Corp manufactures and distributes in vitro diagnostic instruments, reagents, and software. The vast majority of the firm's revenue comes from selling tests for human bodily fluids to hospitals and commercial laboratories. Within this industry, the firm specializes in hematology reagents and instruments. Sysmex also sells in vitro diagnostics for applications like urinalysis and hemostasis and provides support and maintenance services for its systems. Over half of the firm's revenue is generated by sales of reagents and services, which are recurring sources of income. Sysmex primarily sells its products to customers in Japan, Europe, the Middle East, and Africa, and the Americas.

Sysmex (Sysmex) Headlines

From GuruFocus

Vanguard Health Care Fund Gains 4 International Stocks in 2nd Quarter

By Sydnee Gatewood Sydnee Gatewood 08-04-2017

Matthews Japan Fund Comments on Sysmex

By Vera Yuan Vera Yuan 02-05-2015

Matthews Japan Fund Q4 2014 Commentary

By Vera Yuan Vera Yuan 02-05-2015

Matthews Japan Fund Comments on Sysmex

By Sydnee Gatewood Sydnee Gatewood 10-21-2020